FY2025 Earnings Forecast for CVE:HIV Issued By Roth Capital

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Roth Capital cut their FY2025 EPS estimates for shares of HIVE Blockchain Technologies in a report released on Thursday, January 30th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings per share of ($0.53) for the year, down from their previous forecast of ($0.52). Roth Capital has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q1 2026 earnings at ($0.10) EPS, Q2 2026 earnings at $0.01 EPS, Q3 2026 earnings at ($0.03) EPS, Q4 2026 earnings at $0.19 EPS, FY2026 earnings at $0.10 EPS, FY2027 earnings at $0.62 EPS and FY2028 earnings at $0.06 EPS.

HIVE Blockchain Technologies (CVE:HIV) last announced its quarterly earnings results on Tuesday, November 12th. The company reported C($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.12) by C$0.04. During the same quarter in the prior year, the company earned ($0.39) EPS.

Several other equities research analysts have also recently commented on HIV. Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a research report on Wednesday, January 8th. Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th. Four analysts have rated the stock with a strong buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Strong Buy”.

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.